[Clinical variability of polyvinylpyrrolidone dermatosis].
Several pharmaceutics on the market contain polyvinylpyrrolidone (PVP). As the high-polymeric parts of the PVP molecules cannot be eliminated after parenteral or subcutaneous application, they accumulate in the organism. PVP residues in the dermis cause a considerable variability of skin changes, ranging from deposits nearly without reactions up to swelling, papules, granulomas and pseudotumors.
D003877:Dermatitis, Contact / Q000209:etiology* / Q000473:pathology; D006801:Humans; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D011205:Povidone / Q000009:adverse effects* / Q000378:metabolism
D011205:Povidone
Zur klinischen Varianz der Polyvinylpyrrolidon-Dermatose.